Harriet Lane Handbook
Ivacaftor
Kalydeco
Cystic fibrosis transmembrane conductance regulator potentiator
| B | ? | Yes | Yes | Yes |
| Key |
- Oral granules: 25 mg (56 packets), 50 mg (56 packets), 75 mg (56 packets)
- Tabs: 150 mg (56 tabs)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Hughes, Helen K., and Lauren K. Kahl, editors. "Ivacaftor." Harriet Lane Handbook, 23rd ed., Elsevier, 2024. Harriet Lane, www.unboundmedicine.com/harrietlane/view/Harriet_Lane_Handbook/310179/all/Ivacaftor.
Ivacaftor. In: Hughes HKH, Kahl LKL, eds. Harriet Lane Handbook. Elsevier; 2024. https://www.unboundmedicine.com/harrietlane/view/Harriet_Lane_Handbook/310179/all/Ivacaftor. Accessed October 23, 2026.
Ivacaftor. (2024). In Hughes, H. K., & Kahl, L. K. (Eds.), Harriet Lane Handbook (23rd ed.). Elsevier. https://www.unboundmedicine.com/harrietlane/view/Harriet_Lane_Handbook/310179/all/Ivacaftor
Ivacaftor [Internet]. In: Hughes HKH, Kahl LKL, eds. Harriet Lane Handbook. Elsevier; 2024. [cited 2026 October 23]. Available from: https://www.unboundmedicine.com/harrietlane/view/Harriet_Lane_Handbook/310179/all/Ivacaftor.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ivacaftor
ID - 310179
ED - Hughes,Helen K,
ED - Kahl,Lauren K,
BT - Harriet Lane Handbook
UR - https://www.unboundmedicine.com/harrietlane/view/Harriet_Lane_Handbook/310179/all/Ivacaftor
PB - Elsevier
ET - 23
DB - Harriet Lane
DP - Unbound Medicine
ER -
